Abstract
Health care delivery revolves around accurate documentation, with data management free from error. A seemingly insignificant typographical error can cause short- and long-term problems that may lead to inaccurate records and misinformation. This report presents an overview of input errors in the US Food and Drug Administration Adverse Event Reporting System (FAERS). The focus is on errors and inconsistencies in reporting of drug names in the FAERS database, initiated through input of the MedWatch reporting system. The consequences from erroneous data input—in this case, drug names—can have an impact on data integrity, research, and patient safety.
Keywords
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
